Mark Stanley Berger Genprex, Inc. (GNPX) insider trading activity

Mark Stanley Berger is Chief Medical Officer of Genprex, Inc.. Currently has a direct ownership of 4,806 shares of GNPX, which is worth approximately $7,689. The most recent transaction as insider was on Feb 18, 2024, when has been sold 1,319 shares (Common Stock) at a price of $4.4 per share, resulting in proceeds of $5,803. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.81K

0% 3M change

98.04% 12M change

Total Value Held $7,689

Mark Stanley Berger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 18 2024	SELL Payment of exercise price or tax liability	$5,803 $4.4 p/Share	1,319 Reduced 21.53%	4,806 Common Stock
Feb 18 2023	BUY Grant, award, or other acquisition	-	245,000 Added 50.0%	245,000 Common Stock

Also insider at

ATNM

Actinium Pharmaceuticals, Inc. Healthcare

Chief Medical Officer

MSB